Ocular morbidity associated with intravitreal triamcinolone acetonide.
about
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionIntravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionSevere intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population.Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edemaComparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Treatment of steroid-induced elevated intraocular pressure with anecortave acetate: a randomized clinical trial.Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Endophthalmitis after intravitreal injections.The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.Steroid-induced iatrogenic glaucoma.Safety of intravitreal triamcinolone acetonide: an electrophysiologic and histopathological study in rabbits.Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections.Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema.Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone.
P2860
Q24187275-24E2FD95-AB00-4ED0-A839-2FBAE22D81BCQ24240914-630C0F03-830D-4895-BCC0-1DC9865AB303Q30850809-5413E172-074E-40C2-9F1C-B094650E8FDBQ30863562-94022652-90E1-47B0-9EE6-9397A801A07CQ33303367-C5F95D8C-5A6A-4BFD-AEDF-0B34007DFA90Q34942261-98F33DE3-0674-41F7-8FD8-E7AFB52B99BFQ35009731-B5BF89D4-8B8A-4E47-8989-761760B5B476Q35097904-D08FD3E0-D408-4C08-8DD5-093CC89BE8D7Q35167647-6BF35C05-8A51-49F0-A389-D79951B827A9Q36421784-EA2D4A67-842C-47F3-8642-9D34A1788C35Q37069615-6DC47804-1D50-40A2-9930-D5189F81E506Q37477129-E0867AAD-FA89-4C85-B928-1CFF8C00CBA1Q37544827-BA142D03-64C8-4B9A-9F7E-7E041EFA843AQ37859399-BDEB9112-2F38-4D0D-A9FF-513990E7EB57Q37901293-14113DBF-D58B-4FB8-893C-2AEF003115C6Q41895584-3ABE9658-AD85-461B-8AD2-2D0233EF5185Q42634677-D9C69911-9FA7-420F-B208-B6857F2F761BQ42857767-F6BED0D9-C12F-4FB0-8F7B-F301DC97AAE3Q47145465-1C823816-46EE-46E5-88A4-E874DA61C061
P2860
Ocular morbidity associated with intravitreal triamcinolone acetonide.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@ast
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@en
type
label
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@ast
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@en
prefLabel
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@ast
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@en
P2093
P2860
P356
P1433
P1476
Ocular morbidity associated with intravitreal triamcinolone acetonide.
@en
P2093
A Konstantopoulos
C P R Williams
R S Newsom
P2860
P2888
P304
P356
10.1038/SJ.EYE.6702416
P577
2006-05-19T00:00:00Z
P5875
P6179
1013325873